Sam So

444 total citations
10 papers, 330 citations indexed

About

Sam So is a scholar working on Hepatology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sam So has authored 10 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hepatology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sam So's work include Renal Transplantation Outcomes and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Neonatal Health and Biochemistry (2 papers). Sam So is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Neonatal Health and Biochemistry (2 papers). Sam So collaborates with scholars based in United States and Canada. Sam So's co-authors include Carlos O. Esquivel, Nancy L. Ascher, Oscar Salvatierra, Ronald W. Busuttil, Anthony M. D’Alessandro, Sue V. McDiarmid, M. E. Schwartz, Münci Kalayoğlu, J. Marsh and James F. Burdick and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Transplantation.

In The Last Decade

Sam So

10 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sam So United States	6	139	119	106	74	65	10	330
Kiyohide Toki Japan	9	62 0.4×	34 0.3×	134 1.3×	84 1.1×	70 1.1×	30	320
Ryan A. McTaggart United States	8	237 1.7×	80 0.7×	173 1.6×	105 1.4×	120 1.8×	9	496
Wenzel Schoening Germany	13	298 2.1×	195 1.6×	103 1.0×	39 0.5×	58 0.9×	33	466
Kristene K. Gugliuzza United States	11	172 1.2×	31 0.3×	301 2.8×	75 1.0×	42 0.6×	17	442
R.J. Penkrot United States	7	283 2.0×	293 2.5×	39 0.4×	32 0.4×	23 0.4×	9	436
T. Besse Belgium	11	127 0.9×	23 0.2×	54 0.5×	36 0.5×	46 0.7×	21	317
Ane Miren Andrés Spain	13	245 1.8×	51 0.4×	76 0.7×	31 0.4×	72 1.1×	42	424
Paola Violi Italy	9	89 0.6×	56 0.5×	76 0.7×	49 0.7×	23 0.4×	17	219
L. C. Paul Netherlands	10	148 1.1×	17 0.1×	210 2.0×	42 0.6×	23 0.4×	22	380
Roxana Bologa United States	5	186 1.3×	25 0.2×	209 2.0×	70 0.9×	39 0.6×	10	375

Countries citing papers authored by Sam So

Since Specialization

Citations

This map shows the geographic impact of Sam So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam So more than expected).

Fields of papers citing papers by Sam So

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam So. The network helps show where Sam So may publish in the future.

Co-authorship network of co-authors of Sam So

This figure shows the co-authorship network connecting the top 25 collaborators of Sam So. A scholar is included among the top collaborators of Sam So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam So. Sam So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Lin, Allen, George A. Fisher, Sam So, Chao Tang, & Lee Levitt. (2005). A phase II study of imatinib mesylate (IM) in patients (pts) with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 23(16_suppl). 4223–4223. 3 indexed citations

Lin, Albert Y., N A Brophy, George A. Fisher, et al.. (2004). Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer. 103(1). 119–125. 51 indexed citations

Millan, Maria T., William E. Berquist, Sam So, et al.. (2003). One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience1. Transplantation. 76(10). 1458–1463. 75 indexed citations

Johnson, Jeremy A., et al.. (2001). <title>Real-time freehand 3D ultrasound system for clinical applications</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4319. 724–730. 2 indexed citations

Millan, Maria T., Sam So, Minnie Sarwal, et al.. (2000). EARLY COMBINED KIDNEY AND LIVER TRANSPLANTATION FOR INFANTS WITH TYPE I HYPEROXALURIA YIELDS 100% LONG-TERM GRAFT SURVIVAL.. Transplantation. 69(Supplement). S276–S276. 1 indexed citations

Salvatierra, Oscar, Robert H. Mak, Edward J. Alfrey, et al.. (1997). Pediatric renal transplantation and its challenges. Transplantation Reviews. 11(2). 51–69. 34 indexed citations

McDiarmid, Sue V., Ronald W. Busuttil, Nancy L. Ascher, et al.. (1995). FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER TRANSPLANTATION. Transplantation. 59(4). 530–536. 128 indexed citations

Woodle, E. Steve, et al.. (1993). Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.. PubMed. 25(2). 1988–9. 1 indexed citations

Jendrisak, Martin D., D. Phelan, J.W. Marsh, et al.. (1991). Significance of B-cell crossmatch on outcome in renal transplantation.. PubMed. 23(1 Pt 1). 434–6. 7 indexed citations

10.

Bumgardner, Ginny L., Sally Chen, Rosemary A. Hoffman, et al.. (1989). AFFERENT AND EFFERENT PATHWAYS IN T CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES. Transplantation. 47(1). 163–170. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact